Global Veterinary Rapid Test Market Size study, by Product (Test Kits, Readers), by Technology (Immunoassays, PCR), by Animal Type, by Testing Category, by End-use and Regional Forecasts 2022-2032

Global Veterinary Rapid Test Market is valued approximately at USD 0.82 billion in 2023 and is anticipated to grow with a robust compound annual growth rate of more than 12.33% over the forecast period 2024-2032. In the face of escalating zoonotic risks, rising pet ownership, and heightened food safety scrutiny, the veterinary rapid test industry has emerged as a pivotal segment of the global animal healthcare ecosystem. These rapid tests offer near-instant diagnostic results for infectious diseases, metabolic disorders, and parasitic infections-enabling veterinarians and livestock managers to make timely, data-driven decisions. Their speed, portability, and growing affordability are revolutionizing point-of-care diagnostics for both production and companion animals, leading to a paradigm shift away from centralized lab testing and towards decentralized, field-friendly solutions.

The market's trajectory is being accelerated by a confluence of factors including technological breakthroughs in immunodiagnostics, multiplex PCR systems, and lateral flow assay formats that enhance sensitivity and specificity. Veterinary professionals are increasingly relying on these tests for routine screening, surveillance, and outbreak management, particularly in rural and underserved regions where laboratory infrastructure is limited. Furthermore, the proliferation of digital readers and cloud-based data integration is transforming how results are stored, analyzed, and shared-supporting a broader shift toward connected veterinary care. However, despite these advancements, certain challenges persist. Variability in regulatory approvals across countries, limitations in pathogen detection ranges, and concerns over false positives can hinder the universal adoption of these tests.

Strategic partnerships between diagnostic companies and veterinary institutions are becoming increasingly common, fostering the co-development of species-specific test kits tailored to regional disease burdens. The market is also witnessing the rapid development of multiplex assays capable of detecting multiple pathogens in a single test, a capability that offers enormous utility in both livestock biosecurity and pet diagnostics. Additionally, manufacturers are focusing on reducing the overall cost-per-test to expand their reach into emerging markets, where veterinary expenditure has historically been low but is now climbing due to governmental support and growing commercial farming operations.

Another tailwind boosting market adoption is the intensifying emphasis on antimicrobial stewardship. Rapid tests that offer conclusive results within minutes allow for targeted therapy and reduce the reliance on broad-spectrum antibiotics-a practice closely monitored by global health bodies like the WHO and OIE. The veterinary community is also increasingly leveraging these tests in preventive care programs, wellness checkups, and pre-purchase evaluations, further embedding them into daily veterinary workflows.

Regionally, North America remains a frontrunner, thanks to its advanced veterinary infrastructure, strong presence of key market players, and high pet ownership rates. Europe closely follows, driven by stringent animal health regulations and government-backed disease eradication initiatives. Meanwhile, the Asia Pacific region is forecasted to witness the fastest growth, underpinned by growing livestock populations, intensifying disease surveillance programs, and rising awareness among pet owners. Latin America and the Middle East & Africa are also catching up, as international investments improve diagnostic capabilities across veterinary clinics and farms.

Major market player included in this report are:

• Zoetis Inc.
• IDEXX Laboratories, Inc.
• Heska Corporation
• Virbac
• Thermo Fisher Scientific Inc.
• BioNote Inc.
• Neogen Corporation
• Randox Laboratories Ltd.
• Fassisi GmbH
• Biopanda Reagents Ltd.
• IDVet
• Woodley Equipment Company Ltd.
• BioChek BV
• Skyer, Inc.
• MEGACOR Diagnostik GmbH

The detailed segments and sub-segment of the market are explained below:

By Product

• Test Kits
• Readers

By Technology

• Immunoassays
• PCR

By Animal Type

• Companion Animals
• Livestock Animals

By Testing Category

• Infectious Disease
• Metabolic Disorders
• Others

By End-use

• Veterinary Hospitals & Clinics
• Diagnostic Laboratories
• Research Institutions

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.